-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Arrowhead Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$176M, a 71.5% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$547M, a 203% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$205M, a 14.8% decline from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$179M, a 19.8% decline from 2021.
- Arrowhead Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$149M, a 60% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)